Valuation: Artivion, Inc.

Market Cap 1.04B 930M 867M 786M 1.48B 98.86B 1.49B 10.39B 4.07B 51.41B 3.91B 3.83B 165B P/E 2026 *
-61x
P/E 2027 * 80.6x
Enterprise Value 1.04B 930M 867M 786M 1.48B 98.86B 1.49B 10.39B 4.07B 51.41B 3.91B 3.83B 165B EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.92x
Free-Float
89.42%
Yield 2026 *
-
Yield 2027 * -
1 day-1.97%
1 week-2.20%
Current month-6.40%
1 month-14.83%
3 months-11.11%
6 months-44.62%
Current year-53.17%
1 week 20.21
Extreme 20.21
22.4
1 month 20.21
Extreme 20.21
25.75
Current year 19.16
Extreme 19.16
46.84
1 year 19.16
Extreme 19.16
48.25
3 years 12.16
Extreme 12.1582
48.25
5 years 9.64
Extreme 9.64
48.25
10 years 9.64
Extreme 9.64
48.25
Manager TitleAgeSince
Chief Executive Officer 59 2014-09-01
Director of Finance/CFO 53 2023-12-03
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 2003-11-30
Director/Board Member 66 2003-11-30
Director/Board Member 61 2012-04-30
Date Insider Type Main position Quantity % Market Cap. Importance
9/10/26 Sell

General Counsel

-11,480 0.0235%
9/3/26 Sell

General Counsel

-1,493 0.0031%
8/19/26 Sell

Chief Executive Officer

-70,000 0.1442%
Change 5-day change 1-year change 3-year change Capi.($)
-1.97%-2.20%-47.43%+59.28% 1.06B
+0.78%+4.53%-21.90%+12.92% 176B
+1.17%+6.80%-2.69%+29.25% 118B
-0.02%+1.56%-22.57%+9.57% 108B
-0.31%-0.27%-46.72%-10.85% 75.34B
+1.55%+4.34%+4.14%+74.68% 62.03B
+1.48%+2.21%+21.12%+68.90% 52.8B
-0.80%+3.92%+0.38%-27.57% 51.45B
-0.69%+0.95%-17.84%+22.09% 41.28B
-1.00%+2.00%+30.46%+11.64% 32.42B
Average +0.02%+2.41%-10.31%+24.99% 71.86B
Weighted average by Cap. +0.44%+3.40%-11.90%+19.68%

Financials

2026 *2027 *
Net sales 490M 438M 408M 370M 697M 46.55B 702M 4.89B 1.91B 24.21B 1.84B 1.8B 77.69B 543M 485M 452M 410M 772M 51.56B 778M 5.42B 2.12B 26.82B 2.04B 2B 86.05B
Net income -16.53M -14.77M -13.77M -12.48M -23.49M -1.57B -23.67M -165M -64.56M -816M -62.09M -60.73M -2.62B 11.4M 10.18M 9.49M 8.6M 16.19M 1.08B 16.32M 114M 44.49M 563M 42.8M 41.86M 1.81B
Net Debt - -
Projected Income Statement - Annual - Artivion, Inc.
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change Volume
26-10-13 US$21.36 -1.97% 664,563
26-10-12 US$21.79 +2.49% 436,617
26-10-09 US$21.26 +0.24% 343,497
26-10-08 US$21.21 -1.85% 602,174
26-10-07 US$21.61 -1.05% 351,961
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Artivion, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
21.36USD
Average target price
42.15USD
Spread / Average Target
+97.33%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Artivion, Inc.
  1. Stock Market
  2. Stocks
  3. AORT Stock